Delivery Order SPE2DB22D3016-SPE2DB25FBDG4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,160.01 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. ENBREL is a biologic immunosuppressant commonly used to treat rheumatoid arthritis, psoriasis, and other autoimmune...
- The Defense Logistics Agency awarded a delivery order valued at $22,877.90 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors. The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a firm fixed-price procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving...
- The Defense Logistics Agency awarded a $37,508.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Enbrel 50 mg/mL SureClick auto-injector pens. This competitively awarded contract, which carries no set-aside designation, was finalized on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Enbrel is a biologic immunosuppressant commonly prescribed for rheumatoid...
- The Defense Logistics Agency awarded a delivery order valued at approximately $82.1K to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant used to treat rheumatoid arthritis, psoriasis,...
- The Defense Logistics Agency awarded a $35,070.68 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with an ultimate completion date of July 23, 2025. This non-set-aside contract was competitively awarded on July 22, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $13,844.92 delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's established role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,592.67 to AmerisourceBergen Drug Corp for the supply of ENBREL 50 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract was executed on July 21, 2025, with an ultimate completion date of July 22, 2025, and reflects a firm fixed price arrangement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $30,598.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 24, 2025. This non-set-aside contract represents a competitive procurement of a specialized pharmaceutical product—a biologic medication used primarily for rheumatoid arthritis and other autoimmune conditions—to support federal medical supply needs. AmerisourceBergen Drug Corp, headquartered...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Enbrel 50 mg/ml SureClick auto-injectors, valued at $59,347.67. This firm fixed-price delivery order, which is a child contract under a larger vehicle, represents a competitive award with no set-aside designation. The order is scheduled for completion by July 25, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency (DLA) awarded a $28,810.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors. The contract, which was awarded on July 21, 2025, with a completion date of July 22, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBDG4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $38,403.45 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 29, 2025. This competitive, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL is a biologic immunosuppressant used to treat rheumatoid arthritis, psoriasis, and other inflammatory conditions, and its inclusion in the federal medical supply chain reflects DLA's commitment to ensuring adequate pharmaceutical inventory for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen leverages this prime contract vehicle to supply an extensive portfolio of brand-name and generic medications, vaccines, specialty drugs, and medical devices to support military healthcare programs worldwide. The company's consistent receipt of competitively awarded delivery orders across multiple therapeutic domains demonstrates its capability to meet stringent federal procurement requirements and serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.4k | 7/28/25 |